top of page
.png)
Accelerating Medical Innovation
Providing funding and support to medical practitioner's to advance new medical device innovations to market.
The Company following it's regulated listing on a designated stock exchange will enter into new inovative medical device opportunities.
PureFlowCath Catheter
The Company is developing PureFlowCath Catheter, the first urinary catheter system to provide continuous irrigation (CSCI) with the objective of reducing urinary tract infections.
-
Capital provided to date: US$ 8.35 million
-
Patents awarded including EU
-
Patents securitised in Luxembourg
-
Prospectus for admission to Toronto Stock
-
Exchange Venture advanced
bottom of page